Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kim

Showing results (241-250 of 512) with videos related to

Pageof 52
Sort By:
Physical Review Letters|September 26, 2012
Observation of reactor electron antineutrinos disappearance in the RENO experimentJ K Ahn, S Chebotaryov, J H Choi, et al.
ESMO Open|September 25, 2025
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)S-A Im, K Park, J Koh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 15, 2023
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upS Loibl, F André, T Bachelot, et al.
ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2020
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)F Cardoso, S Paluch-Shimon, E Senkus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2026
A Randomized Phase III Trial of Anthracyclines Followed by Taxane versus Taxane Plus Carboplatin as (Neo)Adjuvant Therapy in Patients with Triple-Negative Breast Cancer: KCSG BR 15-1 PEARLY TrialG M Kim, K H Jung, H C Jeung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survivalY Wang, D Drubay, S F Jonas, et al.
Physical Review Letters|March 14, 2025
First Measurement of Missing Energy due to Nuclear Effects in Monoenergetic Neutrino Charged-Current InteractionsE Marzec, S Ajimura, A Antonakis, et al.
Physical Review Letters|February 7, 2003
Indications of neutrino oscillation in a 250 km long-baseline experimentM H Ahn, S Aoki, H Bhang, et al.
Physical Review Letters|January 17, 2012
Search for differences in oscillation parameters for atmospheric neutrinos and antineutrinos at Super-KamiokandeK Abe, Y Hayato, T Iida, et al.
Pageof 52

Showing results (241-250 of 512) with videos related to

Sort By:
Pageof 52
Physical Review Letters|September 26, 2012
Observation of reactor electron antineutrinos disappearance in the RENO experimentJ K Ahn, S Chebotaryov, J H Choi, et al.
ESMO Open|September 25, 2025
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)S-A Im, K Park, J Koh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 15, 2023
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upS Loibl, F André, T Bachelot, et al.
ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2020
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)F Cardoso, S Paluch-Shimon, E Senkus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2026
A Randomized Phase III Trial of Anthracyclines Followed by Taxane versus Taxane Plus Carboplatin as (Neo)Adjuvant Therapy in Patients with Triple-Negative Breast Cancer: KCSG BR 15-1 PEARLY TrialG M Kim, K H Jung, H C Jeung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survivalY Wang, D Drubay, S F Jonas, et al.
Physical Review Letters|March 14, 2025
First Measurement of Missing Energy due to Nuclear Effects in Monoenergetic Neutrino Charged-Current InteractionsE Marzec, S Ajimura, A Antonakis, et al.
Physical Review Letters|February 7, 2003
Indications of neutrino oscillation in a 250 km long-baseline experimentM H Ahn, S Aoki, H Bhang, et al.
Physical Review Letters|January 17, 2012
Search for differences in oscillation parameters for atmospheric neutrinos and antineutrinos at Super-KamiokandeK Abe, Y Hayato, T Iida, et al.
Pageof 52